Norwegian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
anticancer/breast neoplasms
Koblingen er lagret på utklippstavlen
Side 1 fra 242 resultater
Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND
Cancer is a group of diseases characterized by aberrant control of cell growth. The annual incidence of cancer is estimated to be in excess of 1.3 million in the United States alone. While surgery, radiation, chemotherapy, and hormones are used to treat cancer, it remains the second
Compositions and methods for monitoring breast cancer treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
Glutamine supplementation has been shown to prevent induction of mammary (breast) cancer in rats by the carcinogen 7,12-dimenthyl-benz[a]anthracene (DMBA) (Feng, Z., et al., Surgical Forum 47:524 526 (1996)). It has also been shown to enhance the effectiveness of
Compositions and methods for monitoring breast cancer treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
Glutamine supplementation has been shown to prevent induction of mammary (breast) cancer in rats by the carcinogen 7,12-dimenthyl-benz[a]anthracene (DMBA) (Feng, Z., et al., Surgical Forum 47:524-526 (1996)). It has also been shown to enhance the effectiveness of
Compositions and methods for monitoring breast cancer treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
Glutamine supplementation has been shown to prevent induction of mammary (breast) cancer in rats by the carcinogen 7,12-dimenthyl-benz[a]anthracene (DMBA) (Feng, Z., et al., Surgical Forum 47:524-526 (1996)). It has also been shown to enhance the effectiveness of
Markers for identifying breast cancer treatment modalities
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
Breast cancer is the most frequently diagnosed cancer and the second most common cause of cancer death in women. While endocrine therapies have proven to be initially effective, almost half of breast cancer patients eventually present recurrent tumors that are resistant
Tissue specific adenovirus vectors for breast cancer treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
Tissue specific adenovirus vectors target breast cancer cells with genes that encode products that kill the cells.
Despite important advances in early detection and treatment, breast cancer remains a major cause of death, with more than 40,000 deaths expected in the U.S. alone in 1996. Even with
Predicting breast cancer treatment outcome
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
The invention relates to the identification and use of gene expression profiles, or patterns, with clinical relevance to the treatment of breast cancer using tamoxifen (nolvadex) and other "antiestrogen" agents against breast cancer, including other "selective estrogen
Methods for breast cancer treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
Disclosed herein are methods for treating breast cancer comprising predicting or assessing the efficacy of a therapeutic regimen for breast cancer and administering an effective amount of a therapeutic agent to treat breast cancer in subjects. Specifically, disclosed are
Methods of breast cancer treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
The present invention relates generally to the field of adjuvant methods and devices for breast cancer treatment. Specifically, brachytherapy methods to treat a tumor, preferably a breast tumor, are described.
BACKGROUND OF THE INVENTION
One method of treating breast cancer is
Method for determining breast cancer treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
The present invention relates to a method for determining a treatment procedure for breast cancer, a method of predicting a clinical response to a breast cancer treatment, and a method for selecting an endocrine therapy agent in treating breast cancer. In general, methods of
Collagens as markers for breast cancer treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
The claimed methods relate to biomarkers of breast cancer and methods of use thereof.
BACKGROUND
Breast carcinomas represent a heterogeneous group of tumors at the clinical, histopathologic, and molecular levels (Cancer Genome Atlas Network, Nature 490:61-70, 2012). The diversity of
Antitumor activity of multi-kinase inhibitors in triple negative breast cancer
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is filed under the provisions of 35 U.S.C. .sctn.371 and claims the priority of International Patent Application No. PCT/EP2015/061641, filed on 27 May 2015 entitled "ANTITUMOR ACTIVITY OF MULTI-KINASE INHIBITORS IN TRIPLE NEGATIVE BREAST
Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
This invention relates to (among other things) the field of cancer chemotherapy. More specifically, the invention involves the treatment of an individual suffering from a cancer such as breast cancer by administering to the individual a long-acting topoisomerase I inhibitor,
Prevention of mammary carcinogenesis and breast cancer treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
The present invention relates to the use of the functional ingredients inulin, oligofructose or their derivatives for the manufacture of functional food, functional feed, OTC and pharmaceutical compositions for the prevention of mammary carcinogenesis or treatment of breast cancer. The invention
Prostate and breast cancer treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
The invention provides methods and compositions comprising steroids or analogs, such as analogs of androst-5-ene-3.beta.,17.beta.-diol ("AED") or 1,3,5(10)-estratriene-17.alpha.-ethynyl-3.beta.,17.beta.-diol ("EED") for use as agents to modulate the biological activity of
Den mest komplette databasen med medisinske urter støttet av vitenskap
- Fungerer på 55 språk
- Urtekurer støttet av vitenskap
- Urtegjenkjenning etter bilde
- Interaktivt GPS-kart - merk urter på stedet (kommer snart)
- Les vitenskapelige publikasjoner relatert til søket ditt
- Søk medisinske urter etter deres effekter
- Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter
Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot.
* All informasjon er basert på publisert vitenskapelig forskning
